Error: Could not add to watchlist. X
+ Watchlist

Generex Biotechnology Corp

GNBT:US
Ticker Change
GNBT:US has changed to a new ticker symbol
0.007
USD
6.993
99.90%
As of 8:10 PM EDT 3/13/2017
Volume
2,207,751
Previous Close
7.000
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
2,207,751
Previous Close
7.000
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.01%
% Price Change
+0.10%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.
Address
33 Harbour Square
Suite 202
Toronto, ON M5J 2G2
Canada
Phone
1-416-364-2551
Show More